Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Novel adenosine antagonists revealed by Fujisawa

Dec. 2, 1997

Genset sequences Chlamydia pneumoniae

Dec. 2, 1997

FDA approves Gensia Laboratories' generic bumetanide injection

Dec. 1, 1997

AVID study results reported

Dec. 1, 1997

Pharmacological profile and antihypertensive effects of YM-358

Dec. 1, 1997

Bayer focuses on agents for atherosclerosis

Dec. 1, 1997

Antiproliferative effects of new tyrosine kinase inhibitor CGP-53716

Nov. 28, 1997

KRN-4884: mechanism of action of new KATP channel opener

Nov. 28, 1997

Bayer patents new antiatherosclerotic agents

Nov. 28, 1997

Pharmacological profile of TH-142177, a new AT1 receptor antagonist

Nov. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...